Acetyl-Histone H3 (Lys23) Antibody

What is the biological significance of Histone H3 Lysine 23 acetylation?

Histone H3 Lysine 23 (H3K23ac) acetylation represents an important post-translational modification that influences chromatin structure and gene expression. As a core component of nucleosomes, Histone H3 plays a central role in DNA packaging. Acetylation at Lys23 removes the positive charge on the histone, decreasing interaction with negatively charged DNA phosphate groups, which results in a more relaxed chromatin structure that facilitates access for transcription machinery .

Unlike better-characterized histone modifications such as H3K9ac or H3K27ac, H3K23ac has distinct functions in various cellular processes including transcription regulation, DNA repair, DNA replication, and maintenance of chromosomal stability . Studies have shown that H3K23ac is often enriched in actively transcribed regions, suggesting its role in gene activation.

How does H3K23ac differ from other histone H3 acetylation marks?

H3K23ac exhibits distinct genomic distribution patterns compared to other histone H3 acetylation marks:

Specificity testing data shows that anti-Acetyl-Histone H3 (Lys23) antibodies such as clone RM169 specifically react to Histone H3 acetylated at Lysine 23 with no cross-reactivity to other acetylated lysines including K4ac, K9ac, K14ac, K18ac, K27ac, K36ac, K56ac, K79ac, or K122ac in histone H3 .

What are the optimal conditions for detecting H3K23ac by Western blot?

To achieve optimal detection of H3K23ac by Western blot:

• Sample preparation:

  • Extract histones using acid extraction methods (typically with sulfuric acid or hydrochloric acid)

  • For cell samples, treatment with HDAC inhibitors like sodium butyrate enhances detection of acetylation marks

• Gel electrophoresis:

  • Use 15-18% SDS-PAGE gels for optimal separation of histone proteins

  • Load 10-20 μg of acid-extracted histones per well

• Antibody dilutions:

  • Primary antibody: The recommended dilution varies by product

    • For polyclonal antibodies: 1:500-1:2000

    • For monoclonal antibodies (RM169): 0.5-2 μg/mL

  • Longer incubation times (overnight at 4°C) can improve sensitivity

• Controls:

  • Positive control: Acid extracts from sodium butyrate-treated HeLa cells

  • Negative control: Untreated cell extracts or recombinant unmodified histone H3

• Detection:

  • Use ECL systems with moderate to high sensitivity

  • Expected molecular weight: ~17 kDa

Western blot analysis data show that Anti-acetyl-Histone H3 (Lys23) antibody successfully detects a band of acetylated histone H3 at ~17 kDa in sodium butyrate-treated HeLa cells but shows minimal signal in untreated samples .

How should researchers optimize Chromatin Immunoprecipitation (ChIP) protocols for H3K23ac?

Optimizing ChIP protocols for H3K23ac requires:

• Chromatin preparation:

  • Use 1% formaldehyde for 10 minutes at room temperature for crosslinking

  • Sonicate chromatin to 200-500 bp fragments (verify by agarose gel electrophoresis)

  • For H3K23ac, use 1-2 × 10⁶ cell equivalents per IP reaction

• Antibody amounts:

  • For polyclonal antibodies: 2-5 μL per IP reaction

  • For monoclonal antibodies: 1-3 μg per IP reaction

  • Pre-clear chromatin with protein A/G beads before adding antibody

• Controls:

  • Input DNA (typically 5-10% of starting material)

  • IgG control (same species as the primary antibody)

  • Positive control locus: GAPDH promoter region

  • Negative control locus: MyoD (in non-muscle cells)

• Washing and elution:

  • Perform stringent washes to reduce background

  • Gradually increase the stringency of wash buffers

• Data analysis:

  • Present data as percent input

  • For H3K23ac, enrichment at the GAPDH promoter typically shows 5-20× higher signal compared to IgG control

Published ChIP-qPCR data demonstrate successful immunoprecipitation of H3K23ac-associated DNA fragments from HeLa cells, with significant enrichment at the GAPDH promoter compared to negative control loci .

How can researchers validate the specificity of Acetyl-Histone H3 (Lys23) antibodies?

Validating antibody specificity is crucial for reliable experimental results. The following approaches are recommended:

• Peptide competition assays:

  • Pre-incubate the antibody with acetylated H3K23 peptide

  • Signal should be blocked by the specific peptide but not by unmodified or differently modified peptides

• Dot blot analysis with modified peptides:

  • Test against a panel of histone peptides with different modifications

  • Example panel: unmodified K23, K23ac, K4ac, K9ac, K14ac, K18ac, K27ac, K36ac

  • Apply 40 ng and 4 ng of each peptide to assess sensitivity and specificity

• Western blot with HDAC inhibitors or HAT activators:

  • Compare treated vs. untreated samples

  • Sodium butyrate treatment should increase H3K23ac signal

• Knockout/knockdown validation:

  • Use cells with HAT enzymes knockdown that target H3K23

  • Signal should decrease in knockdown cells

• Cross-reactivity testing:

  • Test against recombinant histones with defined modifications

  • RM169 monoclonal antibody shows no cross-reactivity with unmodified K23 or other acetylated lysines in histone H3

Research data from dot blot analysis demonstrate that high-quality Acetyl-Histone H3 (Lys23) antibodies specifically detect K23ac without cross-reactivity to other acetylated lysines at both 40 ng and 4 ng peptide concentrations .

What are the most common issues with false positives/negatives when using H3K23ac antibodies?

Researchers should be aware of several potential issues that can lead to unreliable results:

• False positives:

  • Cross-reactivity with other acetylated lysines (particularly K18ac and K27ac)

  • Non-specific binding to highly abundant proteins

  • Antibody batch variability affecting specificity

  • Some antibodies show cross-reactivity with histone H2B acetylated at Lys15

• False negatives:

  • Epitope masking due to protein-protein interactions

  • Insufficient fixation in ChIP or ICC experiments

  • Over-fixation leading to epitope destruction

  • Degradation of acetylation marks during sample preparation

• Troubleshooting strategies:

  • Always include positive controls (sodium butyrate-treated cells)

  • Use multiple antibody clones when possible

  • For ChIP experiments, add HDAC inhibitors to lysis buffers

  • Consider native ChIP for some applications

  • For Western blots, include recombinant H3K23ac as a standard

• Quantitative considerations:

  • H3K23ac levels vary significantly between cell types

  • Cell cycle stage affects global acetylation levels

  • Consider normalization to total H3 levels for accurate quantitation

How can H3K23ac antibodies be integrated into multi-omics approaches?

Integrating H3K23ac analysis into multi-omics studies requires strategic experimental design:

• ChIP-seq integration:

  • Perform parallel H3K23ac ChIP-seq with RNA-seq to correlate acetylation with gene expression

  • Compare H3K23ac with other histone marks (H3K4me3, H3K27ac) to identify unique regulatory regions

  • Protocol optimization: use 2-5 million cells for standard ChIP-seq or 10,000-50,000 cells for low-input methods

  • Computational analysis should include peak calling and overlap analysis with other genomic features

• Mass spectrometry validation:

  • Use parallel MS approaches to quantify H3K23ac levels across conditions

  • Collaborate with proteomics experts to develop targeted MS methods for histone PTM quantification

  • MS data provides orthogonal validation of antibody-based results

• Multiplexed approaches:

  • For antibody-based multiplexing: 0.2-1 μg/mL has been validated for multiplexed detection

  • CUT&RUN or CUT&Tag methods provide higher resolution with less starting material

  • ChIP-SICAP identifies proteins associated with H3K23ac-marked chromatin regions

• Single-cell approaches:

  • scCUT&Tag allows H3K23ac profiling at single-cell resolution

  • Optimize antibody concentration and washing conditions for low-input samples

  • Consider fixation time carefully (2-5 minutes may be optimal)

Studies using these integrated approaches have revealed that H3K23ac occupancy correlates with specific gene expression patterns and can mark functionally distinct chromatin regions compared to other histone modifications .

What is known about the writers, readers, and erasers of H3K23ac and how can researchers study these interactions?

The H3K23ac regulatory machinery includes specific enzymes and proteins:

• Writers (HATs that acetylate H3K23):

  • The SAGA HAT module containing Gcn5 has been shown to acetylate H3K23

  • Enok in Drosophila regulates H3K23ac

  • Experimental approaches:

    • HAT inhibitor studies (specific inhibitors vs. broad-spectrum)

    • In vitro acetylation assays with purified HAT domains

    • Recombinant histones (such as Recombinant Histone H3 acetyl Lys23) as substrates

• Readers (proteins that bind H3K23ac):

  • Bromodomain-containing proteins can recognize H3K23ac

  • The bromodomain of Gcn5 shows specificity for H3K23ac

  • Experimental approaches:

    • Peptide pull-downs using biotinylated H3K23ac peptides

    • FRAP (Fluorescence Recovery After Photobleaching) to measure binding dynamics

    • Proximity labeling (BioID or APEX) to identify readers in cellular context

• Erasers (HDACs that remove acetylation):

  • Class I HDACs (HDAC1, HDAC2) have been implicated in H3K23ac regulation

  • In Arabidopsis, HDA6 regulates locus-directed heterochromatin silencing and affects H3K23ac levels

  • Experimental approaches:

    • HDAC inhibitor studies with sodium butyrate or TSA

    • In vitro deacetylation assays with purified HDACs

    • Genetic studies with HDAC knockouts/knockdowns

• Functional studies:

  • H3K23ac in active DNA demethylation:

    • In Arabidopsis, regulation of active DNA demethylation involves H3K23ac

    • The RNA-directed DNA methylation pathway interacts with H3K23ac in epigenetic regulation

  • Memory and cognitive function:

    • Active, phosphorylated fingolimod inhibits histone deacetylases and affects H3K23ac levels in memory formation

Advanced biochemical approaches like nucleosome competition assays have revealed processive acetylation by the SAGA HAT module with H3K23 as a target , providing insight into the molecular mechanisms of histone acetylation regulation.

How should researchers interpret contradictory findings when using H3K23ac antibodies from different sources or in different experimental contexts?

When facing contradictory results, researchers should apply the following systematic approach:

• Antibody validation comparison:

  • Compare antibody validation data between vendors

  • Check for differences in:

    • Clonality (polyclonal vs. monoclonal)

    • Host species (rabbit vs. mouse)

    • Immunogen design (peptide length and sequence context)

    • Validation methods employed by manufacturers

• Experimental variables to consider:

  • Cell fixation methods and times (critical for ChIP and ICC)

  • Buffer compositions (salt concentration, detergents, HDAC inhibitors)

  • Incubation times and temperatures

  • Detection methods and sensitivity

• Biological variables:

  • Cell type-specific H3K23ac patterns

  • Cell cycle stage (acetylation levels fluctuate)

  • Confluence and culture conditions

  • Environmental stressors that influence global acetylation

• Resolution strategies:

  • Use orthogonal approaches (different antibody-based methods plus non-antibody methods)

  • Employ reciprocal experimental strategies (gain and loss of function)

  • Perform side-by-side comparisons with identical samples

  • Consider using recombinant H3K23ac protein standards for calibration

  • Employ spike-in normalization for quantitative experiments

• Data integration approaches:

  • Meta-analysis of multiple datasets

  • Develop computational models that account for technical variability

  • Use machine learning approaches to identify consistent patterns across datasets

A comprehensive validation approach helped resolve contradictory findings in studies examining H3K23ac in Arabidopsis, where initially conflicting results were reconciled by careful antibody validation and standardized ChIP protocols .

How is H3K23ac involved in disease processes and what are the methodological considerations for clinical samples?

Research has implicated H3K23ac dysregulation in several disease processes:

• Cancer epigenetics:

  • Altered H3K23ac patterns observed in various cancer types

  • Methodological considerations:

    • Use freshly frozen tissues when possible

    • For FFPE samples, optimize antigen retrieval (citrate buffer, pH 6.0)

    • Compare with matched normal tissues

    • Perform H3K23ac ChIP-seq with cancer-specific peak analysis

• Neurodegenerative disorders:

  • H3K23ac involved in memory formation and neuroplasticity

  • Fingolimod, a drug that affects H3K23ac, facilitates fear extinction memory

  • Methodological considerations:

    • Rapid tissue preservation critical for brain samples

    • Region-specific analysis important due to neuronal heterogeneity

    • Consider single-cell approaches for heterogeneous tissues

• Developmental disorders:

  • H3K23ac patterns reprogram during early embryo development

  • H3K23ac specification during gamete formation is critical

  • Methodological considerations:

    • Ultra-low input methods for limited embryonic material

    • Time-course studies to capture dynamic changes

    • Careful staging of developmental samples

• Clinical sample considerations:

  • Tissue preservation methods significantly impact acetylation detection

  • Post-mortem interval affects histone acetylation stability

  • Consider laser capture microdissection for heterogeneous samples

  • Develop standardized protocols for biomarker applications

Research studying H3K23ac in C. elegans demonstrated the importance of this mark during gamete formation and early embryo development, revealing global reprogramming of histone epigenetic marks that may have implications for developmental disorders .

What are the cutting-edge techniques for studying H3K23ac dynamics in live cells and what special considerations apply?

Investigating H3K23ac dynamics in live cells represents a frontier in epigenetic research:

• Genetically encoded sensors:

  • Modified bromodomain-based fluorescent sensors

  • FRET-based sensors to detect H3K23ac in real-time

  • Considerations:

    • Signal-to-noise optimization

    • Potential perturbation of natural acetylation dynamics

    • Calibration with fixed-cell immunofluorescence

• Live-cell compatible antibody approaches:

  • Cell-permeable antibody fragments (scFv, nanobodies)

  • Protein transduction approaches for full antibodies

  • Considerations:

    • Optimize antibody concentration (1-2 μg/mL typical for immunocytochemistry)

    • Validate specificity in live cell context

    • Compare with fixed-cell immunofluorescence data

• Rapid fixation approaches:

  • Microfluidic "stop-flow" fixation

  • Live-cell imaging followed by rapid fixation

  • Considerations:

    • Timing optimization critical for capturing transient states

    • Compatible fixatives with minimal epitope masking

    • Antibody accessibility after different fixation methods

• Nascent acetylation studies:

  • Metabolic labeling with heavy acetate

  • Inhibitor wash-out with time-course analysis

  • Considerations:

    • Temporal resolution limitations

    • Signal amplification methods may be necessary

    • Combination with live-cell imaging for spatial information

Immunocytochemical staining of HeLa cells treated with sodium butyrate using anti-Acetyl-Histone H3 (Lys23) shows nuclear localization of this mark, which can serve as a reference point for live-cell studies . Advanced visualization with co-staining (actin filaments with fluorescein phalloidin and nuclei with DAPI) provides contextual information about H3K23ac distribution in the nucleus.

What are the most effective strategies for troubleshooting weak or inconsistent H3K23ac signals?

When encountering weak or inconsistent H3K23ac signals, implement these troubleshooting strategies:

• Sample preparation optimization:

  • For histones, ensure complete acid extraction

  • Add HDAC inhibitors (sodium butyrate, TSA, or nicotinamide) to all buffers

  • Minimize freeze-thaw cycles of samples

  • For ChIP, optimize crosslinking time (8-12 minutes typically optimal)

• Antibody optimization:

  • Titrate antibody concentration systematically

    • Western blot: Try 1:500, 1:1000, and 1:2000 dilutions

    • ChIP: Test 1, 2, and 5 μg of antibody per reaction

  • Extend primary antibody incubation (overnight at 4°C)

  • Try different antibody clones

  • For polyclonal antibodies, use different lots

• Signal enhancement strategies:

  • Use high-sensitivity detection substrates

  • Employ signal amplification systems

  • For ChIP-qPCR, optimize primer design and PCR conditions

  • Increase exposure time while monitoring background

• Background reduction:

  • Increase blocking concentration (5% BSA or milk)

  • Add 0.1-0.3% Triton X-100 to antibody dilution buffer

  • Use more stringent washing steps

  • For IP experiments, pre-clear lysates thoroughly

• Systematic controls:

  • Always run sodium butyrate-treated samples as positive controls

  • Include recombinant H3K23ac standards when available

  • Monitor total H3 levels in parallel

  • Validate with orthogonal methods (mass spectrometry)

Research data demonstrates that treatment with HDAC inhibitors like sodium butyrate significantly increases H3K23ac signal detection in Western blot and immunofluorescence applications, making this an essential positive control .

How can researchers overcome epitope masking issues when detecting H3K23ac in different experimental contexts?

Epitope masking can significantly impact H3K23ac detection. Address this challenge with:

• Chromatin structure considerations:

  • For fixed cells/tissues:

    • Test multiple fixation methods (formaldehyde, methanol, DSP)

    • Optimize fixation time (over-fixation enhances masking)

    • Implement epitope retrieval methods:

      • Heat-mediated (citrate buffer, pH 6.0)

      • Enzymatic (trypsin digestion)

      • Detergent-based (0.5% Triton X-100)

• Protein-protein interactions:

  • Use detergents to disrupt weak interactions

  • Add high salt washes (up to 500 mM NaCl)

  • For ChIP, include sonication steps to disrupt chromatin

  • Test native versus cross-linked ChIP protocols

• Competing antibody binding:

  • Sequential antibody application with stripping steps

  • Test monoclonal antibodies that recognize different epitopes

  • Try antibodies raised against longer peptides (9-40 aa region) versus shorter epitopes

• Lysine modification competition:

  • H3K23 can be subject to multiple modifications (acetylation, methylation, ubiquitination)

  • Use antibodies validated against multiple modification states

  • Consider pretreatment with deubiquitinases for certain applications

• Advanced approaches:

  • Proximity ligation assay (PLA) for detecting masked epitopes

  • Mass spectrometry-based approaches that don't rely on antibody accessibility

  • Limited proteolytic digestion before antibody application

Western blot and dot blot experiments using anti-Acetyl-Histone H3 (Lys23) antibodies show that proper sample preparation, particularly acid extraction of histones, is essential for reliable detection, as it helps overcome epitope masking by disrupting protein-protein interactions .